Vivos (RDGL) Gross Margin Growth (3y) (2014 - 2025)
Vivos (RDGL) Gross Margin Growth (3y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.03 Bn | 175.74 Bn | 6.27 Bn | 63.00 |
| 2 | Stryker | 129.38 Bn | 126.50 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 108.86 Bn | 99.64 Bn | 6.41 Bn | 21.00 |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | 15.00 |
| 5 | Edwards Lifesciences | 47.66 Bn | 43.99 Bn | 1.29 Bn | -324.00 |
| 6 | Dexcom | 28.64 Bn | 27.52 Bn | 750.30 Mn | 56.00 |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | -164.00 |
| 8 | Smith & Nephew | 27.02 Bn | 26.44 Bn | - | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn | 311.00 |
| 10 | Vivos | 27.57 Mn | 26.01 Mn | -3,105.00 | 5,250.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5,250.00 |
| Sep 30, 2025 | -58,147.00 |
| Jun 30, 2025 | -31,247.00 |
| Mar 31, 2025 | -11,088.00 |
| Sep 30, 2024 | -3,808.00 |
| Sep 30, 2015 | 3,416.00 |
| Mar 31, 2015 | 2,389.00 |
| Jun 30, 2014 | 520.00 |
| Mar 31, 2014 | 1,487.00 |